Our blog is taking a break. If you’d like to contribute, please contact us. We hope to come back soon.

Articles tagged with: product development

Dec19

Forward progress and future goals: End of the year reflections from the IMPT

Thursday, 19 December 2019 Written by // IMPT Secretariat Staff Tags // contraceptive, innovation, prevention, product development, women

The IMPT offices are always a buzz with activity during the months of November and December. Giving Tuesday, World AIDS Day, as well as general end-of-the year wrap ups—it is a reminder that for organizations like ours, this time of year is a time for increased activism, awareness, and reflection. This year, as the IMPT celebrates a decade of progress in the MPT field, we recognize both forward progress and future goals as we continually work to bring MPTs closer to a reality that will improve the lives of women and girls worldwide.

Nov20

The IMPT develops strategies to advance non-hormonal MPTs

Wednesday, 20 November 2019 Written by // IMPT Secretariat Staff Tags // contraceptives, MPTs, non-hormonal contraceptives, prevention, product development

In 1960, FDA approval of the first hormonal contraceptive—more commonly known as “the pill”—revolutionized sexual and reproductive health, giving women unprecedented control over their fertility for the first time in history. Today, there are a range of contraceptive products available to women across the globe. Of the over 30 MPTs in the product development pipeline, 18 have a contraceptive component combined with protection against select sexually transmitted infections (STIs), including HIV, herpes simplex virus (HSV), and chlamydia. Still, women around the world need more choices. As a woman’s needs change and evolve over her lifespan, having a suite of product options for protection against unplanned pregnancy, HIV, and other STIs remains critical.

Nov20

Market-based targets for MPT development: Expanding the target product profile

Tuesday, 20 November 2018 Written by // IMPT Secretariat Staff Tags // product development, target market

Earlier this year, we wrote a post about Target Product Profiles (TPPs) and the generalized versions that the IMPT developed in 2015 for two MPT product types. As we argue in that post, a product that meets all clinical targets listed in a TPP will not necessarily correlate to its public health impact in the real world. That is, not unless we work to understand what the future end-users of MPTs – who include both the women who will use MPTs to protect their sexual and reproductive health as well as the health providers who will prescribe MPTs for these women – want and need in a product and then integrate those learnings into the product development process. Of course, it is critical that an MPT be efficacious and safe, but how can we expand the product evaluation process to better ensure that future end-users will be able to access, want to try, and continue to use an MPT?

Nov29

Status of the field: MPTs in the product pipeline

Wednesday, 29 November 2017 Written by // IMPT Secretariat Staff Tags // contraception, prevention, product development, STIs, women

Since 2009, when MPTs officially became a “thing,” we have had a lot of conversations about MPTs and answered even more questions. We have spoken with friends, family, colleagues, neighbors, seatmates on plane flights – you name it. Until recently, not many people had heard of MPTs, and we spent a large part of these conversations doing quite a bit of explaining.

Most people we talk to seem universally on board with the concept of MPTs, thinking that it “just makes sense” as a prevention approach. However, because there aren’t many ready-to-use MPTs on the market (condoms being the sole exception) they are also hesitant to get “too excited” about future products still in development. For many, MPTs sound great – but intangible, disconnected from reality.

Nov13

MPTs 101: Why youth providers need to know this term

Monday, 13 November 2017 Written by // IMPT Secretariat Staff Tags // prevention, product development, reproductive health, sexual health

If you are an advocate for youth health and wellbeing, you need to know about multipurpose prevention technologies (MPTs) – innovative tools on the horizon to address a gap in the sexual and reproductive health of women and girls. It’s a long name, but there’s a reason behind that. First, these tools are called multipurpose prevention because they simultaneously protect against various combinations of HIV, other sexually transmitted infections (STIs) AND unintended pregnancy. Second, the add-on of technologies illustrates that the field is developing a range of product types that deliver prevention in innovative ways. This includes intravaginal rings, vaginal inserts, films and patches, vaginal gels combined with barrier methods, implants, oral tablets, long-acting injectables…the list goes on!

Recent Posts

Any thoughts? Contact us to learn more about the submission process.

Share

Spread the word about the promise of MPTs.

Collaborate

We will go further together – join the movement for MPTs.

Contribute

Your financial and in-kind support can help make MPTs a reality.